HeartSciences Inc. HSCS 深 滬
已收盤 02-06 16:00:00 美东时间
2.99
+0.170
+6.03%
華盛通- 最 高3.19
- 今 開2.85
- 成交量 4.48万股
- 最 低 2.85
- 昨 收 2.82
- 總市值 950.28万
- 52周最高 6.47
- 市盈率 靜 --
- 換手率 1.41%
- 52周最低 2.01
- 委 比 -96.08%
- 總股本 317.82万
- 歷史最高 600.00
- 量 比 2.13
- 振 幅 12.06%
- 歷史最低 2.01
- 每 手 1
- 風險率 0.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
HeartSciences Inc. announced a partnership with Cibolo Health to provide MyoVista Insights, a cloud-based ECG management platform, to 123 independent hospitals across six states. This collaboration aims to enhance workflow efficiency, data accessibility, and clinical decision-making through modernized ECG workflows and AI-integrated solutions. The partnership supports HeartSciences' mission to expand access to its platform and improve healthcare ...
01-29 13:30
HeartSciences Secures New Private Financing Through Note Issuance
Heart Test Laboratories, Inc. ( ($HSCS) ) has provided an update. On January 13...
01-17 06:53
美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
2025-12-23 12:32
Ascendiant Capital Maintains Buy on HeartSciences, Raises Price Target to $9.2
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and raises the price target from $9 to $9.2.
2025-12-22 18:38
HeartSciences shares are trading higher after the company reported better-than-expected Q2 EPS results.
HeartSciences shares are trading higher after the company reported better-than-...
2025-12-16 05:31
CORRECTION: Heart Test Laboratories Q2 EPS $(0.85) Beats $(1.69) Estimate, Sales $2.419K Miss $50.000K Estimate
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.69) by 49.7 percent. This is a 62.56 percent increase over losses of $(2.27) per share
2025-12-16 05:24
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
2025-10-02 15:08
Heart Test Laboratories Announces Successful Regulation A Offering
Heart Test Laboratories, Inc. ( ($HSCS) ) has shared an announcement. Heart Tes...
2025-10-02 05:48
Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $9
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 to $9.
2025-10-01 18:27
Heart Test Laboratories Regains Nasdaq Compliance
Heart Test Laboratories, Inc. ( ($HSCS) ) has provided an update. On September ...
2025-09-18 05:22
